- Home
- AORT
AORT
Artivion Inc.
as 12-18-2024 11:30am EST
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | KENNESAW |
| Market Cap: | 1.2B | IPO Year: | 1993 |
| Target Price: | $31.80 | AVG Volume (30 days): | 236.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.48 - $30.45 | Next Earning Date: | 02-13-2025 |
| Revenue: | $384,899,000 | Revenue Growth: | 13.29% |
| Revenue Growth (this year): | 13.04% | Revenue Growth (next year): | 9.66% |
Stock Insider Trading Activity of Artivion Inc. (AORT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Holloway Jean F | AORT | SVP, General Counsel | Dec 11 '24 | Sell | $30.13 | 8,070 | $243,108.75 | 157,897 | |
| Horton Amy | AORT | VP, Chief Accounting Officer | Dec 6 '24 | Sell | $29.36 | 8,754 | $256,949.70 | 135,660 | |
| GREEN ANDREW M | AORT | VP Regulatory | Dec 4 '24 | Sell | $30.00 | 7,618 | $228,540.00 | 33,503 | |
| Horton Amy | AORT | VP, Chief Accounting Officer | Oct 1 '24 | Sell | $26.18 | 12,430 | $325,414.91 | 135,660 |
Latest Artivion Inc. News
AORT Breaking Stock News: Dive into AORT Ticker-Specific Updates for Smart Investing
Argus Research
8 days ago
AORT: What does Argus have to say about AORT?
PR Newswire
9 days ago
Artivion Granted FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis
Argus Research
15 days ago
AORT: Rating increased to a HOLD
Simply Wall St.
18 days ago
Returns On Capital Are Showing Encouraging Signs At Artivion (NYSE:AORT)
Argus Research
a month ago
AORT: What does Argus have to say about AORT?
Simply Wall St.
a month ago
Artivion Third Quarter 2024 Earnings: Beats Expectations
PR Newswire
a month ago
Artivion Reports Third Quarter 2024 Financial Results
Argus Research
a month ago
AORT: Raising target price to $22.00
Compare AORT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AORT Artivion Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.